Aprameya Engineering Limited

Aprameya Engineering Limited

NNSE:APRAMEYA
87.15
INR
+7.55
(+9.48%)
No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Semi-annual Revenue

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Semi-annual Earnings Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Semi-annual Dividends Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

Sector
Distribution services
Industry
Wholesale distributors
Address
Ahmedabad India
IPO Date
Aug 1, 2024
Business
Aprameya Engineering Limited is an India-based healthcare infrastructure and medical equipment solutions provider specializing in the turnkey setup, installation, and maintenance of critical care hospital infrastructure and diagnostic technologies. Founded in 2003 and headquartered in Ahmedabad, Gujarat, India, the company delivers engineering and biomedical solutions to government healthcare institutions, private hospitals, medical colleges, research centers, and diagnostic clinics across India. Aprameya Engineering Limited operates through two primary business segments: Healthcare Infrastructure Solutions and Medical Equipment Trading and Maintenance Services. The company's core products and services comprise the turnkey design, fabrication, supply, installation, testing, and commissioning of modular operation theatres (OT); prefabricated surgical suites and cleanroom environments; Intensive Care Units (ICU), Neonatal Intensive Care Units (NICU), and Pediatric Intensive Care Units (PICU); Medical Gas Pipeline Systems (MGPS), including oxygen generation plants, manifold control panels, and medical vacuum systems; Central Sterile Services Department (CSSD) infrastructure; multi-parameter patient monitoring systems and central nursing monitoring consoles; intensive care ventilators and non-invasive respiratory support devices; advanced anesthesia delivery workstations; defibrillators and cardiac care monitors; electro-surgical generator units; surgical lighting fixtures and electro-hydraulic operating tables; infant incubators, radiant warmers, and phototherapy systems; diagnostic imaging and ultrasound equipment; and post-commissioning technical lifecycle management, encompassing preventive maintenance, emergency repair, annual maintenance contracts (AMC), and comprehensive maintenance contracts (CMC) for critical hospital utilities and biomedical apparatus. In recent corporate and operational developments, Aprameya Engineering Limited completed its initial public offering (IPO) in July 2024, raising growth capital and listing its equity shares on the NSE Emerge platform of the National Stock Exchange of India under the ticker symbol APRAMEYA. The proceeds from the public issue have been deployed to fund working capital needs, enhance bidding capacity for large-scale public health infrastructure modernization tenders, and support geographic expansion beyond its core western India base. Over the past two years, the company has also expanded its vendor alliances with global and domestic medical device manufacturers to broaden its portfolio of specialized surgical and diagnostic equipment offerings.